# Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia

> **NCT04803305** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 18 (actual)

## Conditions studied

- Non-small Cell Lung Cancer
- Pancreatic Cancer
- Colorectal Cancer
- Prostate Cancer
- Breast Cancer
- Ovarian Cancer
- Loss of Appetite
- Fatigue
- Cachexia
- Anorexia

## Interventions

- **DRUG:** PF-06946860
- **DRUG:** Placebo for PF-06946860

## Key facts

- **NCT ID:** NCT04803305
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-11
- **Primary completion:** 2022-04-14
- **Final completion:** 2022-08-09
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04803305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04803305, "Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04803305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*